IHC – CD79a (IHC0042)

Description

IHC – CD79a is an immunohistochemistry (IHC) tissue marker test used in histopathology to detect CD79a antigen expression in formalin-fixed, paraffin-embedded tissue sections. CD79a is a B-cell lineage marker expressed in B lymphocytes from early precursor stages through plasma cells, and it is widely used in the diagnosis, classification, and phenotyping of B-cell lymphomas, leukemias, plasma cell neoplasms, and chronic lymphoproliferative disorders. This stain helps pathologists confirm B-cell origin in suspected hematolymphoid malignancies and is often used as part of an IHC panel along with markers such as CD20, PAX5, CD3, CD138, CD10, BCL6, MUM1, and Ki-67. Mayo Clinic Laboratories notes CD79a stains the cytoplasm and membrane of B lymphocytes and is diagnostically useful for demonstrating B-cell lineage in acute lymphoblastic leukemia, malignant lymphomas, and chronic lymphoproliferative disorders. It is performed by Immunohistochemistry (IHC) on paraffin-embedded tissue, with a typical report availability of 1–3 days.

Report Time

Fasting

Not Required

Reporting Time

48-72 Hours

Gender

Male/Female

Age Group

All Age Group

Pre-Test Instructions:

FFPE tissue required; use positively charged slides; avoid frozen/wet/non-formalin tissue; interpret with pathologist and IHC panel

Parameters Covered

रु 3,000

✔ Home collection available ✔ No hidden charges

Need help? Call 1800-123-4567

IHC – CD79a (IHC0042)

Description

Report Time

Pre-Test Instructions:

Parameters Covered

Find Tests By Categories